CTLA-4 inhibitor (intrathecal)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CTLA-4 inhibitor (intrathecal), covering 2025-05-18 to 2025-05-18. Get the full timeline:
Most recent: Clinical Trial Update: Intrathecal Dual Checkpoint Inhibitor (PD-1 and CTLA-4) in Combination With Pemetrexed for Leptomeningeal Metastasis [Phase 1, Phase 2]